Quattroflow Single-Use Quaternary Diaphragm Pumps Use Polymeric Pump Chamber - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Quattroflow Single-Use Quaternary Diaphragm Pumps Use Polymeric Pump Chamber


Quattroflow’s 1200SU-M Series Single-Use Quaternary Diaphragm Pumps are now available with polyethylene (PE) pump chambers. The injected-molded PE pump chambers are a more cost-effective alternative to standard, solid plastic pump chambers, and are assembled under controlled and clean conditions.  Equipped with a product-wetted plastic-pump chamber that can be replaced as a complete unit, Quattroflow 1200SU-M Series single-use pumps have been specifically designed to meet the needs of bio/pharmaceutical applications. The simple disposal of the pump chamber saves time and money, removing the need for extensive cleaning, sterilization, and complex cleaning validation.

Source: Quattroflow

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges

Click here